Related Experiment Video
Updated: Jul 17, 2025
14:44
Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips
Published on: October 20, 2018
26.7K
Organ-on-a-chip meets artificial intelligence in drug evaluation
Shiwen Deng1, Caifeng Li1,2, Junxian Cao1
1Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Theranostics
|August 31, 2023
Summary
Organ-on-a-chip (OoC) technology offers a promising alternative to traditional drug evaluation, improving animal welfare. Combining OoC with artificial intelligence (AI) will revolutionize drug development and personalized medicine.
Area of Science:
- Biotechnology
- Pharmacology
- Artificial Intelligence
Background:
- Traditional drug evaluation faces challenges including animal welfare concerns and limitations in replicating human physiology.
- Organ-on-a-chip (OoC) technology offers a high-fidelity in vitro model of human organs, addressing some limitations of conventional methods.
Purpose of the Study:
- To review the advancements in Organ-on-a-chip (OoC) platforms and their applications in drug testing, disease modeling, and personalized medicine.
- To explore the synergistic potential of integrating Artificial Intelligence (AI) with OoC technology for enhanced drug evaluation.
Main Methods:
- Review of current Organ-on-a-chip (OoC) platform development and applications.
- Discussion on the integration of Artificial Intelligence (AI) for data processing and automation in OoC systems.
Main Results:
- Organ-on-a-chip (OoC) platforms demonstrate significant promise for drug testing, disease modeling, and personalized medicine.
- The integration of AI with OoC technology can address challenges in large data processing and reproducibility, improving drug evaluation efficiency.
Conclusions:
- Advancements in Organ-on-a-chip (OoC) technology, particularly when combined with AI, are poised to transform the future of drug evaluation.
- The synergy between OoCs and AI presents opportunities to overcome current limitations in pharmaceutical research and development.
